MedPath

Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism

Phase 1
Completed
Conditions
Smoking
Interventions
Other: Brussel Sprouts
Drug: Deuterated Phenanthrene
Registration Number
NCT02999399
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Brief Summary

To determine whether glucobrassicin-rich Brussels sprouts can favorably modify the metabolism of the polycyclic aromatic hydrocarbon deuterated phenanthrene (\[D10\]phe) in current and former smokers

Detailed Description

Subjects will be given 1 microgram of \[D10\]phe, and all urine will be collected for 6 h afterwards to quantify baseline levels of \[D10\]phenanthrene tetraol (\[D10\]pheT) and \[D10\]phenanthrols (\[D10\]HOP). Within 3 days of this baseline measurement, subjects will consume 200 micromoles of glucobrassicin in the form of raw Brussels sprouts (\~200-300 grams) at the study center once daily for 7 consecutive days. Urine will be collected for 24 h after vegetable consumption on days 3 ± 1 and 6 of the feeding intervention for 3,3'-diindolylmethane (DIM) quantification. On day 7 of the feeding intervention, a second dose of 1 microgram of \[D10\]phe will be administered at the study center after vegetable consumption, followed by another 6 h urine collection.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • Adult ≥ 18 years old
  • Current or former smoker by self-report
  • Willing to abstain from cruciferous vegetable consumption other than the study vegetable during the study period
  • Able to understand the experimental nature of the study and provide informed consent
  • Negative urine pregnancy test for women of childbearing potential within 7 days of baseline [D10]phe dosing
Exclusion Criteria
  • Chronic proton pump inhibitor, H2-blocker (i.e., ranitidine, famotidine), and/or calcium carbonate use
  • History of gastric bypass surgery, gastric banding, bowel resection, malabsorption syndromes such as celiac sprue or pancreatic insufficiency, or other conditions that may affect gastric absorption
  • Current use of tobacco products other than cigarettes (i.e. snuff, snuz, smokeless tobacco, cigars, pipes) or use of these products within 3 months of study registration
  • Major or chronic medical disease, including heart disease, poorly controlled diabetes, etc., to be adjudicated by the principal investigator
  • Women who are pregnant, intend to become pregnant within 3 months of the study period, or who are breastfeeding
  • Current or recent (within 12 months) problems with drug use or alcohol dependence by self-report Antibiotic use within 2 months of study enrollment or during the study by self-report Alcohol dependence, abuse, or history of dependence/abuse by self-report Vegetarians
  • History of respiratory tract cancer
  • Use of metronidazole or antabuse during the study
  • Taking ibuprofen, naproxen, other NSAIDs, steroids (except inhaled steroids) within 14 days of study registration
  • Allergy to Brussels sprouts

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
[D10]phe and Brussels sproutsDeuterated PhenanthreneAll subjects are given 1 microgram \[D10\]phe before and after consuming Brussels sprouts once daily for 7 consecutive days.
[D10]phe and Brussels sproutsBrussel SproutsAll subjects are given 1 microgram \[D10\]phe before and after consuming Brussels sprouts once daily for 7 consecutive days.
Primary Outcome Measures
NameTimeMethod
Change in [D10]phenanthrene tetraol7 days

Compare level of urinary \[D10\]phenanthrene tetraol before and after 7 days of Brussels sprout consumption.

Secondary Outcome Measures
NameTimeMethod
Change in [D10]phenanthrols7 days

Compare level of urinary \[D10\]phenanthrene phenanthrols before and after 7 days of Brussels sprout consumption.

Change in [D10]phenanthrene tetraol:[D10]phenanthrol ratio7 days

Compare level of urinary \[D10\]phenanthrene phenanthrols before and after 7 days of Brussels sprout consumption.

Trial Locations

Locations (1)

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath